The widely used C8 phase delivers optimum retention for the analysis of hydrophobic and "sticky" compounds. In combination with Kinetex core-shell technology, this phase gives analysts an excellent high-performance reversed phase alternative for HPLC methods.
Johnson & Johnson is conducting a voluntary recall of millions of oral contraceptive packages in 43 countries outside the U.S., but says there's a "very low" risk that the flawed tablets could cause unplanned pregnancies. The birth control pills are being recalled — but only from pharmacies...
The MX™ Vibro-Energy® round separator has a totally enclosed weight guard that prevents "reach-in" injuries. Making use of the appropriate motor, the MX also complies with ATEX Standards 94/9/EC. The open base construction allows for cleaning underneath the unit, preventing dirt and product build-up to occur.
Treatment for muscular dystrophy, which typically kills patients by their thirties, has not advanced much since the 1980’s. Wall Street Journal reporter Jonathon Rockoff talks about a new generation of drugs that promises to extend patient’s lives by years or decades.
As more adults use prescription drugs, the rate of children being poisoned by them has also dramatically increased. This report details how one family with two young daughters makes sure their prescription drugs stay out of their hands to prevent accidental poisoning.
Renaissance Acquisition Holdings, LLC, a RoundTable Healthcare Partners portfolio company, and GlaxoSmithKline announced today that they have entered into an agreement giving Renaissance the rights in the USA to manufacture, market and sell six dermatology and three anti-viral products from GSK.
Maxygen said it will distribute $68.2 million to $69.6 million, or $2.45 to $2.50 per share, to its shareholders if they approve the liquidation. The company also said James Sulat will resign as CEO and chief financial officer on June 30, and company Chairman Isaac Stein will become its acting CEO and CFO.
Shares of Synta Pharmaceuticals Corp. lost more than a third of their value Monday after the company reported new details from a clinical trial of its cancer drug ganetespib that disappointed investors. The trial was designed to study ganetespib as a secondary treatment for adenocarcinoma, a type of non-small cell lung cancer.
The Food and Drug Administration is reviewing a new interpretation of the key study of Avandia's heart attack risks, which suggests the drug is as safe as older diabetes drugs. At a highly unusual meeting this week, the FDA will ask a panel of experts to vote on a range of options for the drug, including lifting restrictions on its use.
Bruker Corporation today announced that it has signed an exclusive patent license agreement with 3M Company, which allows Bruker to include 3M patented innovations relating to matrix-assisted laser desorption ionization (MALDI) mass spectrometry imaging.
The Medicines Co. plans to buy ProFibrix BV in a deal that will hinge on late-stage study results for a topical powder that the company is developing to stop bleeding during or after surgery. Medicines Co. said Tuesday it will make a $10 million option payment upfront and then will review late-stage results from a study of 719 surgical patients with mild to moderate surgical bleeding.
Vertical blenders are ideal for low shear blending of powders, pellets, granules, fibers and other solids. These blenders feature an auger that turns on its own axis and a mechanical arm that rotates the auger around the conical vessel.
The 4.903 Track-IT™ Information management system enables users to scan tube codes directly into the software. With Micronic Traxcer code reader software now fully integrated with Track-IT users can directly trigger tube or rack barcode scanning from the Track-IT program.
Shares of Bristol-Myers Squibb Inc. and Merck & Co. are up about 5 percent each after the drugmakers announced encouraging results on experimental cancer medicines over the weekend. Both companies' drugs for advanced cases of melanoma are in a new class that helps the patient's immune system...
Vaisala recommends a nine-point process for successful mapping of a GxP-compliant warehouse or storage space. These nine steps will ensure that you take into consideration the most important elements of validation, especially understanding where temperature and humidity pose risks to product quality.